SLAS2026 Topical Interest Groups
Recordings from the SLAS Topical Interest Group sessions at SLAS2026. Discussions within SLAS's 20 Topical Interest Groups take place year-round within CONNECTED, SLAS's online networking platform. You may join a Topical Interest Group discussion at any time.
Key:
Complete
Next
Failed
Available
Locked
3D Printing and Additive Manufacturing
Open to view video. | Closed captions available
Open to view video. | Closed captions available
Automation and Screening in Agri-Tech
Open to view video. | Closed captions available
Open to view video. | Closed captions available
Good food is an important part of maintaining health, and with an increased population and diminishing resources the challenges to improve food provision are increasing. Such challenges include developing stronger and resilient crop cultivars and biopesticides that control pests without harming other species, such as pollinators. Like drug discovery, Agri-Tech researchers require higher throughputs, automation and efficiencies to meet these targets. The Agri-Tech TIG is the place to bring together learnings from drug discovery to aid automation and throughput in Agri-Tech, hopefully some of these developments may even circle back open new avenues for drug discovery. Join us for a round table discussion and short presentations on the cutting edge of Agri-Tech assays and automation.
Encoded Libraries and Biophysical Lead Discovery
Open to view video. | Closed captions available
Open to view video. | Closed captions available
Welcome to our new TIG!
Agenda:
Tim Foley - opening remarks about the plans that Jarrod Walsh (AZ) and I have for the TIG this year; as well as discuss ways to get involved with building this new community.
Following those remarks, our scientific program will include two talks:
Jan Kubicek (Cube Biotech) titled “Automated Membrane protein workflow for Drug Discovery utilizing the NativeMPTM Technology”
and John Guilinger (X-Chem) titled "DEL screening to find high quality, novel hits for GPCRs"
Technology Transfer and CRO/CMO Project Management
Open to view video. | Closed captions available
Open to view video. | Closed captions available
This TIG will be run in a panel format, answering questions such as:
1. How has AI affected your outsourcing processes? What is one surprising thing that you or your organization (or both) have realized?
2. How has the funding crunch impacted your decision(s) for growth internally/externally, particularity as it relates to build/buy decisions?
3. What are some ways your organization is using novel business models, challenges and solutions to optimize technology transfer and outsourcing (e.g., remote work)?
4. How do you obtain new technologies/molecules externally to accelerate the drug development process? How has that changed?
5. How can outsourcing help use R&D resources more efficiently (or does it)?
6. What kinds of research are particularly challenging for technology transfer or outsourcing? What do you keep ‘in-house’ no matter what?